PÁVKOVÁ GOLDBERGOVÁ, Monika, Lenka ŠPINAROVÁ, Jindřich ŠPINAR, Jiří PAŘENICA, Lenka ŠIŠKOVÁ, Ladislav GROCH, Jan MÁCHAL a Anna VAŠKŮ. Difference in angiotensinogen haplotype frequences between chronic heart failure and advanced atherosclerosis patients - new prognostic factor? Physiological Research. Praha: Institute of Physiology, Academy of Sci., 2011, roč. 60, č. 1, s. 55-64. ISSN 0862-8408. |
Další formáty:
BibTeX
LaTeX
RIS
@article{921485, author = {Pávková Goldbergová, Monika and Špinarová, Lenka and Špinar, Jindřich and Pařenica, Jiří and Šišková, Lenka and Groch, Ladislav and Máchal, Jan and Vašků, Anna}, article_location = {Praha}, article_number = {1}, keywords = {RAAS; heart failure; AGT}, language = {eng}, issn = {0862-8408}, journal = {Physiological Research}, title = {Difference in angiotensinogen haplotype frequences between chronic heart failure and advanced atherosclerosis patients - new prognostic factor?}, volume = {60}, year = {2011} }
TY - JOUR ID - 921485 AU - Pávková Goldbergová, Monika - Špinarová, Lenka - Špinar, Jindřich - Pařenica, Jiří - Šišková, Lenka - Groch, Ladislav - Máchal, Jan - Vašků, Anna PY - 2011 TI - Difference in angiotensinogen haplotype frequences between chronic heart failure and advanced atherosclerosis patients - new prognostic factor? JF - Physiological Research VL - 60 IS - 1 SP - 55-64 EP - 55-64 PB - Institute of Physiology, Academy of Sci. SN - 08628408 KW - RAAS KW - heart failure KW - AGT N2 - Numerous association studies have been involved in studying the angiotensinogen (AGT) variants, AGT plasma levels and relations to cardiovascular diseases, such as hypertension, myocardial infarction, coronary heart disease. To investigate a role of AGT G(-6)A and M235T genetic variants for chronic heart failure (CHF) and advanced atherosclerosis (AA), a total of 240 patients with CHF and 200 patients with AA of the Czech origin were evaluated for the study. The study shows the role of polymorphism AGT G(-6)A in genetic background among advanced atherosclerosis patients and chronic heart failure patients (Pg=0.001). This difference was observed also in comparison of AA patients with subgroup of CHF with dilated cardiomyopathy (Pg=0.02; Pa=0.009), and ischemic heart disease (Pg=0.007). The greatest difference between triple-vessel disease and chronic heart failure groups was observed in frequency of GT haplotype (P<0.001) and GGMT associated genotype (P<0.001). Retrospectively, when the subgroups of CHF were compared to AA group (AA vs. IHD with CHF - P < 0.001; and AA vs. DCM - P<0.001) we found the same trend. These results suggest AGT genetic variants as a risk factor for chronic heart failure compared to advanced atherosclerosis disease without heart failure, with a strong difference between IHD patients and chronic heart failure patients with ischemic heart disease, especially in haplotypes and associated genotypes. ER -
PÁVKOVÁ GOLDBERGOVÁ, Monika, Lenka ŠPINAROVÁ, Jindřich ŠPINAR, Jiří PAŘENICA, Lenka ŠIŠKOVÁ, Ladislav GROCH, Jan MÁCHAL a Anna VAŠKŮ. Difference in angiotensinogen haplotype frequences between chronic heart failure and advanced atherosclerosis patients - new prognostic factor? \textit{Physiological Research}. Praha: Institute of Physiology, Academy of Sci., 2011, roč.~60, č.~1, s.~55-64. ISSN~0862-8408.
|